Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dräger Award for Intensive Care Medicine bestowed

02.06.2008
At this year's Congress of the European Society of Anaesthesiology (ESA), Euroanaesthesia 2008, in Copenhagen, the ESA presented the “Dräger Award for Intensive Care Medicine”. The 10,000 Euro endowment was donated by Dräger.

The award went to the working group studying “Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis” in the Department of Anesthesiology, Rigshospitalet, at the Juliane Marie Centre and Copenhagen Trial Unit, University of Copenhagen, Denmark.


During the opening ceremony, Professor Jennifer M Hunter, Chairperson of the ESA Scientific Programme Committee, together with Dr Markus Keussen, Head of Dräger Strategic Business Field Anesthesiology, presented the award to Dr Arash Afshari, representing this working group.

The prize
This annual prize honors significant European research in the field of intensive care medicine published in peer-reviewed intensive care or anesthesiology journals in the preceding year. The prize is given to the anesthetic or intensive care department that produces the article rather than any one research worker.

This year, the Dräger Prize subcommittee of the ESA who judged the prize recognized this working group for their systematic, detailed and methodical approach in a large meta-analysis of the effects of anti-thrombin III in critically ill patients.

With this prize, Dräger wishes to honor scientific endeavors and support advances in the field of critical care medicine.

The award recipients
Dr Afshari’s working group has brought together all the published papers on the role of one of the body’s anti-clotting proteins (which also has anti-inflammatory properties), anti-thrombin III, to study its benefits or harm when it is given to critically ill patients. Data from 3458 patients was available suggesting that this clotting product was not suitable to give to intensive care patients despite its anti-inflammatory effects: the risk of excessive bleeding was too great.

As Chairman of the Dräger Prize Subcommittee, Prof Jennifer M. Hunter MB ChB PhD FRCA, School of Clinical Science (Anaesthesia), University of Liverpool, UK, stated that this paper was selected as it showed the highest standard of scientific study of all the submissions, with results that were most likely to affect future clinical practice.

About Dräger
Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology: Dräger products protect, support and save human life. Founded in 1889, in 2007 the Group achieved sales of 1,819.5 million Euro worldwide and an EBIT of 151.9 million Euro. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Dräger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process - Emergency Care, Perioperative Care, Critical Care, Perinatal Care and Home Mechanical Ventilation.
1) Head of the working group: Dr Arash Afshari; members: Dr Jorn Wetterslev,
Dr Jesper Brok, Dr Ann Moller, all of the Rigshospitalet, at the Juliane Marie Centre the Copenhagen Trial Unit and the Cochrane Anaesthesia Review Group, University of Copenhagen, Denmark.

2) BMJ 2007; 335: 1248-51
Contact for Trade Press:
Birgit Diekmann
Tel.: +49 451 882 1215
E-mail: birgit.diekmann@draeger.com

Birgit Diekmann | Drägerwerk AG & Co. KGaA
Further information:
http://www.draeger.com

More articles from Awards Funding:

nachricht Fraunhofer HHI receives AIS Technology Innovation Award 2018 for 3D Human Body Reconstruction
17.01.2018 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI

nachricht Inspired by nature - scalable chemical factory due to photomicroreactors
11.01.2018 | DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>